Here, the authors present the results of a randomised, double-blind, placebo-controlled trial testing whether clindamycin and live Lactobacillus crispatus CTV-05 (LACTIN-V) improve clinical pregnancy rates in IVF patients with abnormal vaginal microbiota, showing that successful treatment of vaginal dysbiosis was independent and not related to the reproductive success.
- Thor Haahr
- Nina la Cour Freiesleben
- Peter Humaidan
